FHTX Foghorn Therapeutics Inc.

Fundamentals / CIK 0001822462 / USD

Foghorn Therapeutics Inc. reported $112.1M in revenue and net income of $9.42M for the trailing twelve months ended September 30, 2026 (up 924.7% year over year), with a 2.1% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open FHTX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$45.16M$22.58M$0-$104.7MFY 2019 Net Income: -$51.13M2019FY 2020 Revenue: $430KFY 2020 Net Income: -$68.80M2020FY 2021 Revenue: $1.32MFY 2021 Net Income: -$101.3M2021FY 2022 Revenue: $19.23MFY 2022 Net Income: -$108.9M2022FY 2023 Revenue: $34.16MFY 2023 Net Income: -$98.43M2023FY 2024 Revenue: $22.60MFY 2024 Net Income: -$86.62M2024FY 2025 Revenue: $30.91MFY 2025 Net Income: -$74.28M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $30.91M $22.60M $34.16M $19.23M $1.32M $430K --
Research & Development $85.47M $94.53M $109.7M $105.6M $80.33M $57.72M $44.36M
Total Operating Expenses $117.3M $125.3M $142.1M $136.4M $102.1M $68.96M $51.08M
Operating Income -$86.39M -$102.7M -$107.9M -$117.1M -$100.7M -$68.53M -$51.08M
EBITDA -$83.06M -$99.56M -$104.5M -$113.8M -$97.51M -$67.20M -$50.39M
Interest Income $8.74M $11.90M $10.88M $5.67M $59K -- --
Interest Expense -- -- -- -- $1.91M $979K $540K
Income Before Tax -- -$86.62M -$94.20M -$108.9M -- -- --
Income Tax Expense $0 $0 $4.23M $0 -- $0 $0
Net Income -$74.28M -$86.62M -$98.43M -$108.9M -$101.3M -$68.80M -$51.13M
Basic EPS -$1.18 -$1.58 -$2.34 -$2.62 -$2.73 -$6.23 -$12.20
Diluted EPS -$1.18 -$1.58 -$2.34 -$2.62 -$2.73 -$6.23 -$12.20
Basic Shares Outstanding 63.0M 54.9M 42.0M 41.6M 37.2M 11.0M 4.2M
Diluted Shares Outstanding 63.0M 54.9M 42.0M 41.6M 37.2M 11.0M 4.2M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $83.54M $16.07M $3.27M $9.25M $8.15M $7.56M $5.95M $2.86M
Research & Development $18.84M $18.52M $18.26M $22.05M $20.00M $21.79M $21.63M $20.51M
Total Operating Expenses $26.90M $24.88M $24.84M $33.12M $26.65M $28.65M $28.86M $26.86M
Operating Income $56.64M -$8.80M -$21.57M -$23.88M -$18.50M -$21.10M -$22.91M -$24.00M
EBITDA $56.84M -$8.61M -$21.34M -$23.08M -$17.60M -$20.20M -$22.09M -$23.24M
Interest Income $1.53M $1.61M $1.74M $1.71M $2.03M $2.31M $2.69M $3.10M
Income Before Tax -- -- -- -- -- -- -- -$19.50M
Income Tax Expense -- -- -- -- -- -- -- $0
Net Income $58.15M -$7.19M -$19.88M -$21.66M -$15.85M -$17.94M -$18.83M -$19.50M
Basic EPS $0.81 -$0.10 -$0.29 -- -$0.25 -$0.28 -$0.30 --
Diluted EPS $0.80 -$0.10 -$0.29 -- -$0.25 -$0.28 -$0.30 --
Basic Shares Outstanding 71.5M 70.6M 69.5M -- 63.0M 63.0M 62.8M --
Diluted Shares Outstanding 72.6M 70.6M 69.5M -- 63.0M 63.0M 62.8M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $80.88M $55.45M $80.34M $52.21M $101.1M $92.80M $14.98M
Cash & Short-Term Investments $80.88M $55.45M $80.34M $52.21M $101.1M $92.80M $14.98M
Total Current Assets $163.2M $249.6M $240.2M $351.4M $459.6M $190.7M $16.89M
Property, Plant & Equipment, Net $1.92M $9.96M $12.96M $15.31M $17.56M $19.53M $2.68M
Other Non-Current Assets $4.0K $68K $1.11M $2.38M $2.40M $842K $11K
Total Non-Current Assets $34.87M $34.38M $45.73M $53.48M $60.21M $64.91M $5.46M
Total Assets $198.1M $284.0M $285.9M $404.9M $519.8M $255.6M $22.34M
Accounts Payable $4.27M $3.79M $6.26M $5.41M $3.82M $3.68M $3.44M
Short-Term Debt -- -- -- -- -- $0 $4.15M
Deferred Revenue (Current) $43.19M $45.61M $34.55M $32.82M $28.32M $2.02M --
Total Current Liabilities $59.74M $66.99M $58.44M $55.20M $48.69M $18.85M $12.65M
Long-Term Debt -- -- -- -- $0 $19.65M $10.96M
Deferred Revenue (Non-Current) $206.0M $234.5M $268.1M $304.0M $322.7M $12.55M --
Other Non-Current Liabilities $556K $0 $0 $29K $143K $0 --
Total Non-Current Liabilities $246.9M $262.5M $304.7M $349.6M $374.2M $90.56M $11.16M
Total Liabilities $306.6M $329.5M $363.1M $404.8M $422.9M $109.4M $23.81M
Total Debt (incl. Leases) $41.27M $37.13M $45.07M $51.51M $58.33M $82.00M $16.63M
Common Stock $6.0K $6.0K $4.0K $4.0K $4.0K $4.0K --
Retained Earnings -$632.5M -$558.2M -$471.6M -$373.1M -$264.3M -$162.9M -$94.14M
Accumulated Other Comp. Income $24K $135K -$826K -$3.99M -$10K -$7.0K --
Total Stockholders' Equity -$108.5M -$45.53M -$77.19M $112K $96.87M $146.2M -$88.02M
Total Equity -$108.5M -$45.53M -$77.19M $112K $96.87M $146.2M -$88.02M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $80.30M $68.08M $87.66M $80.88M $89.33M $72.57M $61.03M $55.45M
Cash & Short-Term Investments $80.30M $68.08M $87.66M $80.88M $89.33M $72.57M $61.03M $55.45M
Total Current Assets $158.3M $170.0M $188.1M $163.2M $184.1M $203.8M $225.4M $249.6M
Property, Plant & Equipment, Net $1.29M $1.50M $1.71M $1.92M $8.66M $9.51M $10.35M $9.96M
Other Non-Current Assets $21K $3.0K $3.0K $4.0K $5.0K $6.0K $24K $68K
Total Non-Current Assets $32.64M $33.35M $34.10M $34.87M $20.84M $22.39M $33.27M $34.38M
Total Assets $191.0M $203.4M $222.2M $198.1M $205.0M $226.2M $258.7M $284.0M
Accounts Payable $2.17M $3.21M $3.32M $4.27M $3.21M $3.32M $4.07M $3.79M
Deferred Revenue (Current) $18.87M $36.59M $52.30M $43.19M $65.30M $59.72M $51.67M $45.61M
Total Current Liabilities $37.31M $50.58M $64.40M $59.74M $85.09M $77.79M $71.31M $66.99M
Deferred Revenue (Non-Current) $127.4M $193.2M $193.6M $206.0M $193.1M $206.8M $222.4M $234.5M
Other Non-Current Liabilities $247K $350K $453K $556K $656K $757K $856K $0
Total Non-Current Liabilities $167.7M $233.9M $234.2M $246.9M $209.5M $225.1M $249.0M $262.5M
Total Liabilities $205.0M $284.4M $298.6M $306.6M $294.6M $302.9M $320.3M $329.5M
Total Debt (incl. Leases) $43.87M $43.10M $41.99M $41.27M $22.53M $23.70M $34.85M $37.13M
Common Stock $6.0K $6.0K $6.0K $6.0K $6.0K $6.0K $6.0K $6.0K
Retained Earnings -$601.4M -$659.5M -$652.3M -$632.5M -$610.8M -$595.0M -$577.0M -$558.2M
Accumulated Other Comp. Income -$123K -$134K -$133K $24K $24K -$44K $14K $135K
Total Stockholders' Equity -$14.08M -$81.04M -$76.41M -$108.5M -$89.66M -$76.66M -$61.65M -$45.53M
Total Equity -$14.08M -$81.04M -$76.41M -$108.5M -$89.66M -$76.66M -$61.65M -$45.53M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$74.28M -$86.62M -$98.43M -$108.9M -$101.3M -$68.80M -$51.13M
Depreciation & Amortization $3.33M $3.12M $3.45M $3.32M $3.23M $1.33M $693K
Stock-Based Compensation $10.40M $11.89M $16.19M $14.34M $8.38M $2.96M $1.69M
Change in Payables $481K -$2.48M $846K $1.61M $135K $474K $1.21M
Operating Cash Flow -$86.10M -$100.4M -$118.1M $193.6M -$50.25M -$31.29M -$46.34M
Capital Expenditure -$50K -$906K -$1.22M -$1.21M -$3.31M -$16.18M -$968K
Free Cash Flow -$86.15M -$101.3M -$119.3M $192.4M -$53.56M -$47.47M -$47.30M
Purchases of Investments -$131.2M -$261.5M -$73.90M -$409.3M -$99.98M -$92.98M --
Investing Cash Flow $112.0M -$29.90M $144.4M -$244.3M $36.17M -$108.9M -$964K
Common Stock Issued -- $103.4M $0 -- -- -- --
Financing Cash Flow $1.02M $105.4M $1.78M $1.76M $22.42M $217.5M $23.97M
Net Change in Cash $26.96M -$24.88M $28.12M -$48.95M $8.34M $77.27M -$23.33M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income $58.15M -$7.19M -$19.88M -$21.66M -$15.85M -$17.94M -$18.83M -$19.50M
Depreciation & Amortization $200K $200K $238K $802K $900K $900K $827K $761K
Stock-Based Compensation $2.52M $2.55M $2.38M $2.24M $2.73M $2.73M $2.69M $2.48M
Change in Payables -$1.03M -$69K -$990K $1.05M -$110K -$747K $284K $334K
Operating Cash Flow -$18.24M -$17.84M -$25.27M -$22.27M -$18.86M -$21.00M -$23.97M -$24.52M
Capital Expenditure -$7.0K -$50K $0 $0 $0 -$22K -$28K -$479K
Free Cash Flow -$18.25M -$17.89M -$25.27M -$22.27M -$18.86M -$21.02M -$24.00M -$25.00M
Purchases of Investments -$13.60M -$37.08M -$66.94M -$33.98M -$4.00M -$42.14M -$51.12M -$39.65M
Investing Cash Flow $24.19M -$2.97M -$17.72M $13.23M $35.57M $33.83M $29.40M $22.29M
Common Stock Issued -- $0 $50.00M -- $0 $0 $0 --
Financing Cash Flow $6.28M -$22K $49.77M $581K $49K $254K $139K $4.0K
Net Change in Cash $12.22M -$20.83M $6.79M -$8.46M $16.76M $13.09M $5.57M -$2.22M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -279.5% -454.3% -315.9% -609.2% -7637.1% -15937.4% --
Net Profit Margin -240.3% -383.2% -288.2% -566.3% -7681.6% -16000.0% --
Return on Equity (ROE) -- -- -- -97216.1% -104.6% -47.1% --
Return on Assets (ROA) -37.5% -30.5% -34.4% -26.9% -19.5% -26.9% -228.8%
Current Ratio 2.73x 3.73x 4.11x 6.37x 9.44x 10.12x 1.33x
Quick Ratio 1.35x 0.83x 1.37x 0.95x 2.08x 4.92x 1.18x
Debt to Equity -- -- -- 459.88x 0.60x 0.56x --
Revenue Growth (YoY) +36.8% -33.8% +77.6% +1357.8% +206.7% -- --
Operating Cash Flow Growth (YoY) -- -- -161.0% -- -- -- --
Free Cash Flow Growth (YoY) -- -- -162.0% -- -- -- --
5Y Revenue / Share Growth +1160.8% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin 2.1% -198.0% -301.3% -279.5% -352.9% -380.0% -414.4% -454.3%
Net Profit Margin 8.4% -175.8% -266.9% -240.3% -294.2% -311.9% -342.2% -383.2%
Return on Assets (ROA) 4.9% -31.8% -33.9% -37.5% -35.2% -33.3% -31.1% -30.5%
Current Ratio 4.24x 3.36x 2.92x 2.73x 2.16x 2.62x 3.16x 3.73x
Quick Ratio 2.15x 1.35x 1.36x 1.35x 1.05x 0.93x 0.86x 0.83x
Revenue Growth (YoY) +924.7% +112.7% -45.1% +223.8% +4.4% +9.7% +17.9% -50.5%
Source: SEC EDGAR CompanyFacts (CIK 0001822462) · from September 30, 2019 Data through September 30, 2026 · synced Nov 20, 2026, 05:48 UTC · Open in terminal